acetazolamide has been researched along with Bone Diseases, Developmental in 2 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Bone Diseases, Developmental: Diseases resulting in abnormal GROWTH or abnormal MORPHOGENESIS of BONES.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moey, LH | 1 |
Flaherty, M | 1 |
Zankl, A | 1 |
van Dalsem, VF | 1 |
Genant, HK | 1 |
Newton, TH | 1 |
2 other studies available for acetazolamide and Bone Diseases, Developmental
Article | Year |
---|---|
Optic disc swelling in acromicric and geleophysic dysplasia.
Topics: Acetazolamide; Bone Diseases, Developmental; Child; Child, Preschool; Female; Humans; Limb Deformiti | 2019 |
Progressive diaphyseal dysplasia. Report of a case with thirty-four years of progressive disease.
Topics: Acetazolamide; Adult; Bone Diseases, Developmental; Camurati-Engelmann Syndrome; Dexamethasone; Huma | 1979 |